Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 10/2/20221 min de lectura
Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry; Availability
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Development of Non-Opioid Analgesics for Acute Pain." In connection with the SUPPORT for Patients and Communities Act (SUPPORT Act), the purpose of this guidance is to spur the development of alternatives to opioids for the management of acute pain by providing information about product development-related issues, "opioid-sparing" claims, and expedited programs as they pertain to this purpose.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →